VERMODJE – Fenilver

Description

Nandrolone Phenylpropionate has mostly been used to treat postmenopausal or senile osteoporosis in women, as well as advanced breast cancer in women, as an adjuvant therapy.  It has historically also been used for a range of other things.

Therapeutic indication

Competitive athletes, bodybuilders, and powerlifters utilise NPP to improve their physiques and performance. According to reports, nandrolone esters are the most often used AAS among athletes and bodybuilders. This is partly because nandrolone has a strong anabolic to androgenic impact ratio and little tendency to have androgenic or estrogenic side effects.

Why choose Nandrolone Phenylpropionateover conventional medicine?

NPP was initially reported in 1957, and it was made available for use in medicine in 1959. Initially utilised for a wide range of indications, its usage was restricted starting in the 1970s, and its primary applications were the treatment of breast cancer and osteoporosis in females. NPP is currently quite rare. The nandrolone decanoate, which has been used more frequently in comparison, was launched in 1962 after the drug, which was the first version of nandrolone to be presented.

Pharmacological actions

The drug’s active form, nandrolone, is produced by the body from NPP. When injected intramuscularly, it has a prolonged elimination half-life in the body. NPP has a considerably shorter elimination half-life and action duration than nandrolone decanoate.

Usage Directions

It is taken once per few days to once each week and has an average duration of effect of one week.

Side effects

• hirsutism
• voice deepening.
• hoarseness of the voice